Biodesix, Inc.
BDSX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $198,395 | $151,088 | $96,837 | $144,761 |
| - Cash | $26,245 | $26,284 | $43,088 | $32,712 |
| + Debt | $61,976 | $60,691 | $31,850 | $10,012 |
| Enterprise Value | $234,126 | $185,495 | $85,599 | $122,061 |
| Revenue | $71,323 | $49,087 | $38,212 | $54,506 |
| % Growth | 45.3% | 28.5% | -29.9% | – |
| Gross Profit | $55,750 | $36,077 | $24,058 | $23,988 |
| % Margin | 78.2% | 73.5% | 63% | 44% |
| EBITDA | -$29,217 | -$37,103 | -$51,531 | -$35,473 |
| % Margin | -41% | -75.6% | -134.9% | -65.1% |
| Net Income | -$42,931 | -$52,146 | -$65,447 | -$43,159 |
| % Margin | -60.2% | -106.2% | -171.3% | -79.2% |
| EPS Diluted | -6.6 | -12.8 | -31 | -31.6 |
| % Growth | 48.4% | 58.7% | 1.9% | – |
| Operating Cash Flow | -$48,649 | -$22,870 | -$44,972 | -$28,223 |
| Capital Expenditures | -$3,230 | -$23,062 | -$3,534 | -$2,547 |
| Free Cash Flow | -$51,879 | -$45,932 | -$48,506 | -$30,770 |